HUN vs ZBH · rev $6.04B vs P/E 23, rev $4.26B
Huntsman Corporation (HUN) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Huntsman Corporation (HUN) is a chemicals company listed on NYSE.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported HUN revenue for 2024-12-31 was $6.04B. Net income was -$127.0M. Revenue was down 1.2% from 2023-12-31 to 2024-12-31. HUN currently screens at market cap $2.23B.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
HUN currently screens at market cap $2.23B. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the HUN and ZBH stock pages for the full models.
Not investment advice.